FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

372510000: Fosinopril (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197803012 Fosinopril (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211045011 Fosinopril en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2764671000005116 Fosinopril da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fosinopril (substance) Is a Angiotensin-converting enzyme inhibitor true Inferred relationship Some
Fosinopril (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Angiotensin-converting enzyme inhibitor (disposition) true Inferred relationship Some
Fosinopril (substance) Is a kemisk stof specificeret iht. funktion false Inferred relationship Some
Fosinopril (substance) Is a Amino acid derivative (substance) true Inferred relationship Some
Fosinopril (substance) Is a Ester true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Fosinopril sodium Is a False Fosinopril (substance) Inferred relationship Some
Product containing fosinopril (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosinopril (substance) Inferred relationship Some 1
Fosinopril adverse reaction Causative agent True Fosinopril (substance) Inferred relationship Some 1
allergi over for fosinopril Causative agent False Fosinopril (substance) Inferred relationship Some
Product containing fosinopril and hydrochlorothiazide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosinopril (substance) Inferred relationship Some 1
fosinopril 10 mg + hydrochlorthiazid 12,5 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fosinopril (substance) Inferred relationship Some
fosinopril 20 mg + hydrochlorthiazid 12,5 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fosinopril (substance) Inferred relationship Some
Non-allergic hypersensitivity to fosinopril Causative agent False Fosinopril (substance) Inferred relationship Some
Non-allergic hypersensitivity to fosinopril Causative agent False Fosinopril (substance) Inferred relationship Some 2
Non-allergic hypersensitivity to fosinopril Causative agent True Fosinopril (substance) Inferred relationship Some 1
fosinopril 10 mg + hydrochlorthiazid 12,5 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Fosinopril (substance) Inferred relationship Some 2
fosinopril 20 mg + hydrochlorthiazid 12,5 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fosinopril (substance) Inferred relationship Some 2
fosinopril 20 mg + hydrochlorthiazid 12,5 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Fosinopril (substance) Inferred relationship Some 2
fosinopril 10 mg + hydrochlorthiazid 12,5 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fosinopril (substance) Inferred relationship Some 1
fosinopril 10 mg + hydrochlorthiazid 12,5 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Fosinopril (substance) Inferred relationship Some 1
fosinopril 20 mg + hydrochlorthiazid 12,5 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Fosinopril (substance) Inferred relationship Some 1
Fosinopril sodium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Fosinopril (substance) Inferred relationship Some
fosinopril 10 mg + hydrochlorthiazid 12,5 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Fosinopril (substance) Inferred relationship Some 2
fosinopril 20 mg + hydrochlorthiazid 12,5 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Fosinopril (substance) Inferred relationship Some 1
Product containing fosinopril in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosinopril (substance) Inferred relationship Some 1
Product containing fosinopril and hydrochlorothiazide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosinopril (substance) Inferred relationship Some 1
Product containing only fosinopril (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosinopril (substance) Inferred relationship Some 1
Product containing only fosinopril and hydrochlorothiazide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosinopril (substance) Inferred relationship Some 1
Product containing only fosinopril and hydrochlorothiazide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosinopril (substance) Inferred relationship Some 1
Product containing only fosinopril in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosinopril (substance) Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

US English

Back to Start